Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer L Kelly

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|May 1, 2016
Consolidative Radioimmunotherapy After Chemoimmunotherapy in Patients With Histologic Transformation of Indolent Non-Hodgkin LymphomaPatrick M Reagan, Andrea Baran, Jennifer L Kelly, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2012
Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphomaTithi Biswas, Eva Culakova, Jonathan W Friedberg, et al.
Leukemia & Lymphoma|October 26, 2011
High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab eraMakiko Ban-Hoefen, Jennifer L Kelly, Steven H Bernstein, et al.
Clinical Immunology (Orlando, Fla.)|January 31, 2012
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletionPaul M Barr, Chungwen Wei, James Roger, et al.
Veterinary Surgery : VS|July 21, 2011
Lymphocyte populations in joint tissues from dogs with inflammatory stifle arthritis and associated degenerative cranial cruciate ligament rupturePeter Muir, Jennifer L Kelly, Sarah Jane Marvel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2011
Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic eraSarah F Keller, Jennifer L Kelly, Elizabeth Sensenig, et al.
Annals of Epidemiology|November 14, 2012
The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of genderJennifer L Kelly, Zachary S Fredericksen, Mark Liebow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA StudiesJennifer L Kelly, Gilles Salles, Bryan Goldman, et al.
Blood|January 18, 2011
The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphomaJonathan W Friedberg, Julie M Vose, Jennifer L Kelly, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 22, 2010
Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphomaJennifer L Kelly, Anne J Novak, Zachary S Fredericksen, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical Lymphoma, Myeloma & Leukemia|May 1, 2016
Consolidative Radioimmunotherapy After Chemoimmunotherapy in Patients With Histologic Transformation of Indolent Non-Hodgkin LymphomaPatrick M Reagan, Andrea Baran, Jennifer L Kelly, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 9, 2012
Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphomaTithi Biswas, Eva Culakova, Jonathan W Friedberg, et al.
Leukemia & Lymphoma|October 26, 2011
High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab eraMakiko Ban-Hoefen, Jennifer L Kelly, Steven H Bernstein, et al.
Clinical Immunology (Orlando, Fla.)|January 31, 2012
Syk inhibition with fostamatinib leads to transitional B lymphocyte depletionPaul M Barr, Chungwen Wei, James Roger, et al.
Veterinary Surgery : VS|July 21, 2011
Lymphocyte populations in joint tissues from dogs with inflammatory stifle arthritis and associated degenerative cranial cruciate ligament rupturePeter Muir, Jennifer L Kelly, Sarah Jane Marvel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2011
Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic eraSarah F Keller, Jennifer L Kelly, Elizabeth Sensenig, et al.
Annals of Epidemiology|November 14, 2012
The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of genderJennifer L Kelly, Zachary S Fredericksen, Mark Liebow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA StudiesJennifer L Kelly, Gilles Salles, Bryan Goldman, et al.
Blood|January 18, 2011
The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphomaJonathan W Friedberg, Julie M Vose, Jennifer L Kelly, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 22, 2010
Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphomaJennifer L Kelly, Anne J Novak, Zachary S Fredericksen, et al.
Pageof 3